Employment and health of people with severe mental illness

ISRCTN ISRCTN13736301
DOI https://doi.org/10.1186/ISRCTN13736301
Submission date
19/03/2025
Registration date
14/05/2025
Last edited
01/07/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Employment is a critical pathway to recovery and community integration for people with psychotic experiences. It is a process that requires community support networks. The aim of this study was to evaluate non-vocational outcomes (symptomatology, hospital admissions, relapses, self-concept, quality of life and global functioning) when incorporating people with SMI to employment

Who can participate?
The inclusion criteria used were the following: age between 18 and 65 years, diagnosis of schizophrenia (DSM-5 TR), capacity to consent participation in the study, being clinically stable without acute psychotic symptoms or having been hospitalized during the last months, being followed by the public community mental health teams during the study and being motivated to obtain a job.

What does the study involve?
Our purpose is to know if in a context of high unemployment rates people with SMI, benefit in their results not vocations to obtain and maintain competitive employment with IPS, versus vocational Rehabilitation

What are the possible benefits and risks of participating?
None

Where is the study run from?
Canary Island (Tenerife). Spain

When is the study starting and how long is it expected to run for?
April 2024 to January 2025

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Francisco Pulido, fpulido@ull.edu.es

Contact information

Dr Francisco Rodriguez Pulido
Scientific, Principal Investigator

Hospital Universitario de Canarias
La Laguna
38200
Spain

Phone +34 (0)609116523
Email fpulido@ull.edu.es
Dr Dacil Oramas
Principal Investigator

Santa Cruz de Tenerife
Santa Cruz de Tenerife
38003
Spain

Phone +34 (0)615912995
Email dacilop@hotmail.com
Dr Nayra Caballero
Public

Calle Suarez Guerra 19
Santa Cruz De Tenerife
38003
Spain

Phone +34 (0)609752202
Email nayra.caballero@universidadeuropea.es

Study information

Study designOpen community-based multicenter controlled experimental randomized study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Workplace
Study typeQuality of life
Participant information sheet No participant information sheet available
Scientific titleThe impact of employment on the health of people with severe mental disorder
Study objectivesIn a context where the individual finds and maintains employment with the support of an evidence-based strategy, such as the individual placement and support (IPS) strategy, individuals with severe mental illness (SMI) who find employment will improve their non-vocational outcomes related to income, hospitalizations, and quality of life
Ethics approval(s)

Approved 01/04/2024, Universidad Europea De Canarias (La Orotava, Santa Cruz de Tenerife, 38005, Spain; +34 (0)609752202; nayra.caballero@universidadeuropea.es), ref: CI 2024-669

Health condition(s) or problem(s) studiedSevere mental illness
InterventionIntervention group: Individual Placement and Support strategy, developed in the United States by Becker and Drake (Becker and Drake, 1993), which states that competitive employment should be as quickly as possible based on preferences, of people wit SMI,integration with mental health team and employment technicians , followed with unlimited supports and zero exclusion.

Control group: the traditional vocational strategy. Understand it is better train skills and then place people with SMI.
The participants in this study were recruited from the Community Mental Health Teams (ECSM) and basic health areas.
The participants were recruited from the Community Mental Health Teams (ECSM) and basic health areas. A sample size of 24 patients per group was estimated, which was increased by 30% due to possible losses to follow-up, leaving a total of 32 patients per group.

A total of 557 participants were recruited from the mental health team and a total of 63 people met the selection criterio and were randomly and blindly assigned each group.

At baseline and at 6-month follow-up, different test batteries were used.
Intervention typeOther
Primary outcome measureMeasured at baseline and 6 months:
1. Self-concept: Test de autoconcepto AF5
2. Quality of life: Test de calidad de vida de Lancashire y Escala de Satisfacción con la Vida (ESV)
3. Test Groningen Social Disabilities Schedule (GSDS)
4. Autonomy: Escala de Evaluación Global de Funcionamiento (Test Global Assessment Scale, GAF)
5. Symptomatology: Positive and Negative Syndrome Scale; Escala de ansiedad-depresión (HADS)
Secondary outcome measuresHospitalization: number of persons who during the last 6 months have been admitted to short- or medium-stay beds at the discretion of their regular psychiatrist measured using patient records
Overall study start date01/04/2024
Completion date20/01/2025

Eligibility

Participant type(s)Service user
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants550
Total final enrolment63
Key inclusion criteria1. Have a diagnosis of schizophrenia according to DSM-5 criteria
2. Have the capacity to consent to voluntary participation in the study, after having been informed of its objectives
3. Be clinically stable, that is, have no acute psychotic symptoms and have not been hospitalized in the last few months
4. Be monitored by the USMC Psychiatry Service (Community Mental Health Unit) during the study
5. Be motivated to obtain regular employment
Key exclusion criteria1. Suffering from a common mental disorder (mood disorder) and/or other organic disorder
2. Having a history of head trauma with loss of consciousness
3. Pregnant
Date of first enrolment20/06/2024
Date of final enrolment28/06/2025

Locations

Countries of recruitment

  • Spain

Study participating centre

Sinpromi
Calle Góngora
Santa Cruz De Tenerife
38005
Spain

Sponsor information

SINPROMI
Other

Calle Góngora
Santa Cruz De Tenerife
38005
Spain

Phone +34 (0)922249199
Email sinpromi@tenerife.es
Website https://sinpromi.es
ROR logo "ROR" https://ror.org/040ehf661

Funders

Funder type

Not defined

no funder

No information available

Results and Publications

Intention to publish date01/05/2025
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planData will be anonymised with ethical and legal restrictions

Editorial Notes

01/07/2025: A study contact was updated.
14/05/2025: Trial's existence confirmed by Universidad Europea De Canarias.